Jubilant Pharmova Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 61.90 | 73.70 | 214.40 |
| Operating Expense | 49.20 | 49.80 | 185 |
| Net Profit | 5.80 | 13.60 | 5.30 |
| Net Profit Margin | 9.37 | 18.45 | 2.47 |
| Earning Per Share | 0.36 | 0.86 | 0.33 |
| EBIDTA | 11.50 | 23.20 | 32.30 |
| Effective Tax Rate | 9.45 | 20.92 | 21.43 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 61.90 |
| Operating Expense | 49.20 |
| Net Profit | 5.80 |
| Net Profit Margin | 9.37 |
| Earning Per Share | 0.36 |
| EBIDTA | 11.50 |
| Effective Tax Rate | 9.45 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 784.70 | 810.10 | 725.73 |
| Operating Expenses Annual | 768.20 | 807 | 719.27 |
| Operating Profit Annual | 119.90 | 141 | 132.62 |
| Interest Annual | 29.90 | 18.50 | 10.99 |
| Depreciation | 36.60 | 34.30 | 33.13 |
| Net Profit Annual | 31.60 | 49.90 | 80.49 |
| Tax Annual | 10.10 | 29.40 | 4.23 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 784.70 |
| Operating Expenses Annual | 768.20 |
| Operating Profit Annual | 119.90 |
| Interest Annual | 29.90 |
| Depreciation | 36.60 |
| Net Profit Annual | 31.60 |
| Tax Annual | 10.10 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 11 | 22.50 | 40.35 |
| Cash Flow from Operations | 143.20 | -65.10 | -3.55 |
| Cash Flow from Investing | -40.30 | 31.10 | 93.10 |
| Cash Flow from Financing | -77.80 | 22.50 | -107.37 |
| Cash Flow at the End | 36.10 | 11 | 22.53 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 11 |
| Cash Flow from Operations | 143.20 |
| Cash Flow from Investing | -40.30 |
| Cash Flow from Financing | -77.80 |
| Cash Flow at the End | 36.10 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 15.28 | 17.41 | 18.27 |
| PBIT Margin (%) | 9.12 | 12.07 | 13.19 |
| PBT Margin (%) | 8.82 | 11.42 | 11.99 |
| Net PROFIT Margin (%) | 4.03 | 6.16 | 11.09 |
| Return On Networth / Equity (%) | 1.32 | 2.06 | 4.33 |
| Return On Networth /Employed (%) | 2.57 | 3.60 | 4.31 |
| Return On Assets (%) | 1.13 | 1.85 | 3.66 |
| Total Debt / Equity (X) | 0.15 | 0.11 | 0.18 |
| Asset Turnover Ratio (%) | 0.28 | 0.30 | 0.33 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 15.28 |
| PBIT Margin (%) | 9.12 |
| PBT Margin (%) | 8.82 |
| Net PROFIT Margin (%) | 4.03 |
| Return On Networth / Equity (%) | 1.32 |
| Return On Networth /Employed (%) | 2.57 |
| Return On Assets (%) | 1.13 |
| Total Debt / Equity (X) | 0.15 |
| Asset Turnover Ratio (%) | 0.28 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 711.30 | 687.40 | 636.51 |
| Total Current Assets Annual | 540.60 | 578.80 | 525.81 |
| Non Current Assets Annual | 2,451.30 | 2,429.60 | 2,369.75 |
| Total Shareholders Funds Annual | 2,374.50 | 2,414.50 | 2,439.07 |
| Total Assets Annual | 2,991.90 | 3,008.40 | 2,895.56 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 711.30 |
| Total Current Assets Annual | 540.60 |
| Non Current Assets Annual | 2,451.30 |
| Total Shareholders Funds Annual | 2,374.50 |
| Total Assets Annual | 2,991.90 |
EPS (INR)
Expected
6.51
Reported
6.49
Surprise
-0.31%
Mar 2025
EPS beaten by -0.31%
Dec 2024
EPS beaten by -0.10%
Sep 2024
EPS beaten by -0.31%
